about
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesIdentification of autoreactive B cells with labeled nucleosomesGeneral Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 MiceCharacterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study.IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity.Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis.Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotypePKK deficiency in B cells prevents lupus development in Sle lupus mice.Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.[Therapy-resistant cells of the B cell line].Gene-gene interaction of ATG5, ATG7, BLK and BANK1 in systemic lupus erythematosus.The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis.
P2860
Q28067334-51B11995-3F04-4ABB-9E97-AFF0178DA080Q33674468-23E4E747-D5FD-4776-BD93-42507BC8B56FQ35562921-7192BE50-C3C3-4A7D-B1A0-8C53A4DB6BB1Q36042598-FE66A3F6-26CC-4B0F-B156-AE1DFD1C75FCQ36863144-76D8961A-DD58-4B3F-B30D-E479BB592B0BQ37470883-62EF296A-A3E1-4483-821B-94AA59660D02Q39379152-E835A47A-F162-4BE2-94A9-B0924F324AB1Q41532554-C106BAA0-EBB6-4510-A7DD-CF3E3CE29841Q50678340-2CA77E44-7679-4E63-9611-46F007045616Q50689763-C871FF6F-BD1F-4CC5-A8A1-EF63B0113D8EQ52364003-B9EC5638-7DBD-4CBF-86DE-26FE3CE91CBDQ52726230-B9CC87FC-5977-4068-BA78-A7A73A2B4CC8Q52850241-29FBACE8-0533-4664-B09B-9A558F0B0A9DQ53667453-61ACEF86-8ED7-4A9C-A310-B6E0A7A214F3Q55012595-65F7EC06-4DDE-4C6D-AFA4-83200925E8EF
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rationale for B cell targeting in SLE
@ast
Rationale for B cell targeting in SLE
@en
type
label
Rationale for B cell targeting in SLE
@ast
Rationale for B cell targeting in SLE
@en
prefLabel
Rationale for B cell targeting in SLE
@ast
Rationale for B cell targeting in SLE
@en
P2860
P1476
Rationale for B cell targeting in SLE
@en
P2093
Iñaki Sanz
P2860
P2888
P304
P356
10.1007/S00281-014-0430-Z
P577
2014-04-25T00:00:00Z
P6179
1017427395